Drug Trial Radar · NCT04794101
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
97
Actual
Start
Dec 4, 2020
Primary completion
Sep 20, 2029
Study completion Dec 7, 2029
Sponsor
- Lead sponsor
- MeiraGTx Ocular UK LtdIndustry
- Sponsor type
- Industry
- First posted
- Mar 11, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)
Conditions
- X-Linked Retinitis Pigmentosa
Interventions
Genetic: AAV5-hRKp.RPGR Intermediate DoseBiological
Bilateral, subretinal administration of AAV5-hRKp.RPGR - deferred treatment group
Genetic: AAV5-hRKp.RPGR Low DoseBiological
Bilateral, subretinal administration of AAV5-hRKp.RPGR - deferred treatment group
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Ocular and Non-ocular Adverse EventsTime frame: Day 1 - Month 60
- Number of Participants With Abnormalities in Laboratory AssessmentsTime frame: Day 1 - Month 60
- Change From Baseline in Best Corrected Visual Acuity (BCVA) by Early Treatment Diabetic Retinopathy Study (ETDRS) Chart Letter Score in Monocular AssessmentTime frame: From Baseline - Month 60
- Change From Baseline in Low Luminance Visual Acuity by ETDRS Chart Letter Score in Monocular AssessmentTime frame: From Baseline- Month 60
Locations
28 sites in 11 countries. Site status is shown where the registry gives one.
Shiley Eye Institute Jacobs Retina Center
La Jolla, California
Childrens Hospital Los Angeles
Los Angeles, California
Stanford Health Care
Palo Alto, California
VitreoRetinal Associates, PA
Gainesville, Florida
Emory University
Atlanta, Georgia
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts
Univ of Michigan Medical Center
Ann Arbor, Michigan
Duke Eye Center
Durham, North Carolina
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, Pennsylvania
Retina Consultants of Houston
Bellaire, Texas
Ghent University Hospital
Ghent, Belgium
Hospital For Sick Children
Toronto, Ontario, Canada
Rigshospitalet Glostrup
Glostrup Municipality, Denmark
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Paris, France
Hadassah Medical Center
Jerusalem, Israel
Azienda Ospedaliero Universitaria Careggi
Florence, Italy
Ospedale San Paolo
Milan, Italy
Azienda Ospedaliera Univ.- Università Degli studi della Campania - Luigi Vanvitelli
Naples, Italy
IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS
Rome, Italy
VUMC Amsterdam
Amsterdam, Netherlands
Radboudumc
Nijmegen, Netherlands
Hosp Univ Fund Jimenez Diaz
Madrid, Spain
University Hospital Basel, Eye Clinic/Institute of Molecular and Clinical
Basel, Switzerland
Universite de Lausanne, Hopital ophtalmique Jules-Gonin
Lausanne, Switzerland
NHS Lothian
Edinburgh, United Kingdom
Gartnavel General Hospital
Glasgow, United Kingdom
St James University Hospital
Leeds, United Kingdom
Moorfields Eye Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.